U.S. Food, 2020-06-19: Joint FDA and FTC warning letter to a seller of methylene blue products marketed as COVID-19 preventives and treatments, stating that such products are unapproved new drugs sold in violation of the Food, Drug, and Cosmetic Act.
The FDA has observed that your website offers Methylene Blue products for sale in the United States and that these products are intended to mitigate, prevent, treat, diagnose, or cure COVID-19 [1] in people.
Warning letter, body paragraph 1
U.S. Food, 2020-06-19: Joint FDA and FTC warning letter to a seller of methylene blue products marketed as COVID-19 preventives and treatments, stating that such products are unapproved new drugs sold in violation of the Food, Drug, and Cosmetic Act. Record opened and quoted; the FDA publishes this warning letter as an HTML page only , no direct PDF was issued or linked (a search of the page's links found no /media/ or download URL), so pdf_url is left blank rather than guessed. Issued by FDA's Office of Compliance (Center for Drug Evaluation and Research) with the FTC; reviewed websites theblublock.com (FDA review 28 May 2020, FTC review 17 June 2020). Legal basis quoted in the letter: section 505(a) of the FD&C Act, 21 U.S.C. 355(a). Also filed as MTD-053, MTF-51, MTM-36, MTO-59, MTP-43, MTG-077 (claims C10, C12, C16, C7, C8, C9). Study type: regulatory record.
